LDHA inhibition results in increased apoptosis via ROS production in cell with fumarate hydratase deficiency and was viewed as a therapeutic strategy for the treatment of hereditary leiomyomatosis and renal cell cancer [23]. This evidence concerns the gene LDHA and hereditary leiomyomatosis and renal cell cancer.